Skip to main content

Advertisement

Log in

Incorporating Biologics into the Treatment of Psoriasis

  • Published:
Journal of Cutaneous Medicine & Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIGURE 1
FIGURE 2
FIGURE 3
FIGURE 4
FIGURE 5
FIGURE 6

References

  1. C Robert TS. Kupper (1999) ArticleTitleInflammatory skin diseases, T-cells, and immune surveillance N Engl J Med 341 1817–1828 Occurrence Handle10.1056/NEJM199912093412407 Occurrence Handle1:CAS:528:DC%2BD3cXhsVekuw%3D%3D Occurrence Handle10588968

    Article  CAS  PubMed  Google Scholar 

  2. JC. Prinz (2003) ArticleTitleThe role of T-cells in psoriasis J Eur Acad Dermatol Venereol 17 257–270 Occurrence Handle1:STN:280:DC%2BD3s3jslKqtA%3D%3D Occurrence Handle12702062

    CAS  PubMed  Google Scholar 

  3. Hitt E, Lie D. Biologic agents show efficacy in patients with plaque psoriasis. Medscape Medical Views 2003;www.medscape.com/viewarticle/464696

  4. U. Mrowietz (2001) ArticleTitleAdvances in systemic therapy for psoriasis Clin Exp Dermatol 26 362–367 Occurrence Handle10.1046/j.1365-2230.2001.00835.x Occurrence Handle1:STN:280:DC%2BD3MzmtFyltw%3D%3D Occurrence Handle11422190

    Article  CAS  PubMed  Google Scholar 

  5. JG. Krueger (2002) ArticleTitleThe immunologic basis for the treatment of psoriasis with new biologic agents J Am Acad Dermatol 46 1–23 Occurrence Handle10.1067/mjd.2002.120568 Occurrence Handle11756941

    Article  PubMed  Google Scholar 

  6. CN Ellis GG. Krueger (2001) ArticleTitleTreatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes N Engl J Med 345 248–255 Occurrence Handle10.1056/NEJM200107263450403 Occurrence Handle1:CAS:528:DC%2BD3MXlvVKqs7Y%3D Occurrence Handle11474662

    Article  CAS  PubMed  Google Scholar 

  7. JD Bos C Hagenaars PK Das et al. (1989) ArticleTitlePredominance of ‘memory’ T-cells (CD4+, CDw29+) over ‘naïve’ T-cells (CD4+, CD45R+) in both normal and diseased human skin Arch Dermatol Res 281 24–30 Occurrence Handle1:STN:280:DyaL1M3nt1ajug%3D%3D Occurrence Handle2525009

    CAS  PubMed  Google Scholar 

  8. GS Morganroth LS Chan GD Weinstein et al. (1991) ArticleTitleProliferating cells in psoriatic dermis are comprised primarily of T-cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells J Invest Dermatol 96 333–340 Occurrence Handle10.1111/1523-1747.ep12465237 Occurrence Handle1:STN:280:DyaK3M7mtF2qtw%3D%3D Occurrence Handle2002255

    Article  CAS  PubMed  Google Scholar 

  9. GG Krueger KP. Callis (2003) ArticleTitleDevelopment and use of alefacept to treat psoriasis J Am Acad Dermatol 49 S87–S97 Occurrence Handle10.1016/mjd.2003.552 Occurrence Handle12894131

    Article  PubMed  Google Scholar 

  10. SL Mehlis KB. Gordon (2003) ArticleTitleThe immunology of psoriasis and biologic immunotherapy J Am Acad Dermatol 49 S44–S50 Occurrence Handle10.1016/S0190-9622(03)01134-4 Occurrence Handle12894125

    Article  PubMed  Google Scholar 

  11. JM Brande ParticleVan den H Braat GR Brink Particlevan den et al. (2003) ArticleTitleInfliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease Gastroenterology 124 1774–1785 Occurrence Handle10.1016/S0016-5085(03)00382-2 Occurrence Handle12806611 Occurrence Handle1:CAS:528:DC%2BD3sXlt1yrt7Y%3D

    Article  PubMed  CAS  Google Scholar 

  12. P Ettehadi MW Greaves D Wallach et al. (1994) ArticleTitleElevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions Clin Exp Immunol 96 146–151 Occurrence Handle1:CAS:528:DyaK2cXktVOit7w%3D Occurrence Handle8149659 Occurrence Handle10.1111/j.1365-2249.1994.tb06244.x

    Article  CAS  PubMed  Google Scholar 

  13. L Adorini S. Trembleau (1997) ArticleTitleImmune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes Biochem Soc Trans 25 625–629 Occurrence Handle1:CAS:528:DyaK2sXjs1agurk%3D Occurrence Handle9191169

    CAS  PubMed  Google Scholar 

  14. FD. Finkelman (1995) ArticleTitleRelationships among antigen presentation, cytokines, immune deviation and autoimmune diseases J Exp Med 182 279–282 Occurrence Handle10.1084/jem.182.2.279 Occurrence Handle1:CAS:528:DyaK2MXntFKhsr8%3D Occurrence Handle7543132

    Article  CAS  PubMed  Google Scholar 

  15. JP Callen GG Krueger M Lebwohl et al. (2003) ArticleTitleAAD consensus statement on psoriasis therapies J Am Acad Dermatol 49 897–899 Occurrence Handle10.1016/S0190-9622(03)01870-X Occurrence Handle14576671

    Article  PubMed  Google Scholar 

  16. M Lebwohl A Menter J Koo et al. (2004) ArticleTitleCombination therapy to treat moderate to severe psoriasis J Am Acad Dermatol 50 416–430 Occurrence Handle10.1016/j.jaad.2002.12.002 Occurrence Handle14988684

    Article  PubMed  Google Scholar 

  17. M. Lebwohl (2003) ArticleTitleCombining the new biologic agents with our current psoriasis armamentarium J Am Acad Dermatol 49 S118–S124 Occurrence Handle10.1016/S0190-9622(03)01144-7 Occurrence Handle12894135

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Lui, H., Langley, R., Poulin, Y. et al. Incorporating Biologics into the Treatment of Psoriasis . J Cutan Med Surg 8 (Suppl 1), 8–13 (2004). https://doi.org/10.1007/s10227-004-2003-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10227-004-2003-6

Keywords

Navigation